Literature DB >> 10391848

Detection of anti-VacA antibody responses in serum and gastric juice samples using type s1/m1 and s2/m2 Helicobacter pylori VacA antigens.

G I Perez-Perez1, R M Peek, J C Atherton, M J Blaser, T L Cover.   

Abstract

Several different families of vacuolating toxin (vacA) alleles are present in Helicobacter pylori, and they encode products with differing functional activities. H. pylori strains containing certain types of vacA alleles have been associated with an increased risk for peptic ulcer disease. In this study, we tested serum samples and gastric juice from 19 H. pylori-negative and 39 H. pylori-positive patients for enzyme-linked immunosorbent assay reactivity with two different types of VacA antigens (types s1/m1 and s2/m2), which were purified from H. pylori 60190 and 86-338, respectively. Both antigens were recognized better by serum immunoglobulin G (IgG) from H. pylori-positive persons than by serum IgG from H. pylori-negative persons (P < 0.01). The s1/m1 VacA antigen was better recognized by sera from patients carrying vacA type s1/m1 strains than by sera from patients carrying vacA type s2/m2 or s1/m2 strains (P < 0.01). Conversely, the s2/m2 VacA antigen was better recognized by sera from patients carrying type s2/m2 or s1/m2 strains (P = 0.03). Serum IgG anti-VacA antibodies were present more frequently in patients carrying type s1/m1 strains than in other H. pylori-positive patients (P = 0.0002). In addition, the highest levels of IgA anti-VacA antibodies were detected in the gastric juice of patients carrying type s1/m1 strains. These data indicate that different VacA isoforms have distinct antigenic properties and that multiple forms of VacA elicit antibody responses in H. pylori-positive humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391848      PMCID: PMC95713          DOI: 10.1128/CDLI.6.4.489-493.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  31 in total

1.  Purification and characterization of the vacuolating toxin from Helicobacter pylori.

Authors:  T L Cover; M J Blaser
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

Review 2.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

3.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

4.  Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.

Authors:  T L Cover; P Cao; U K Murthy; M S Sipple; M J Blaser
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.

Authors:  T L Cover; P Cao; C D Lind; K T Tham; M J Blaser
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

7.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

8.  Intrafamilial clustering of Helicobacter pylori infection.

Authors:  B Drumm; G I Perez-Perez; M J Blaser; P M Sherman
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  [IgA-antibodies against Helicobacter pylori in gastric secretions: gastric secretory immune response or salivary contamination?].

Authors:  H P Wirth; P Vogt; R Ammann; J Altorfer
Journal:  Schweiz Med Wochenschr       Date:  1993-05-29

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  10 in total

1.  Antigenic diversity among Helicobacter pylori vacuolating toxins.

Authors:  A D Vinion-Dubiel; M S McClain; P Cao; R L Mernaugh; T L Cover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer.

Authors:  G A Rocha; A M Oliveira; D M Queiroz; A S Carvalho; A M Nogueira
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.

Authors:  Chandrabali Ghose; Guillermo I Perez-Perez; Victor J Torres; Marialuisa Crosatti; Abraham Nomura; Richard M Peek; Timothy L Cover; Fritz Francois; Martin J Blaser
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.

Authors:  C Figueiredo; W Quint; N Nouhan; H van den Munckhof; P Herbrink; J Scherpenisse; W de Boer; P Schneeberger; G Perez-Perez; M J Blaser; L J van Doorn
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

5.  Detection of high titers of antibody against Helicobacter cysteine-rich proteins A, B, C, and E in Helicobacter pylori-infected individuals.

Authors:  Peer R E Mittl; Lucas Lüthy; Christoph Reinhardt; Hellen Joller
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.

Authors:  Tajana Filipec Kanizaj; Miroslava Katicić; Vladimir Presecki; Slavko Gasparov; Vesna Colić Cvrlje; Branko Kolarić; Anna Mrzljak
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

Review 7.  An Overview of Helicobacter pylori VacA Toxin Biology.

Authors:  Nora J Foegeding; Rhonda R Caston; Mark S McClain; Melanie D Ohi; Timothy L Cover
Journal:  Toxins (Basel)       Date:  2016-06-03       Impact factor: 4.546

Review 8.  The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management.

Authors:  Khalid O Alfarouk; Adil H H Bashir; Ahmed N Aljarbou; AbdelRahman M Ramadan; Abdel Khalig Muddathir; Sari T S AlHoufie; Abdelhamid Hifny; Gamal O Elhassan; Muntaser E Ibrahim; Saad S Alqahtani; Shakir D AlSharari; Claudiu T Supuran; Cyril Rauch; Rosa Angela Cardone; Stephan J Reshkin; Stefano Fais; Salvador Harguindey
Journal:  Front Oncol       Date:  2019-02-22       Impact factor: 6.244

Review 9.  Use of VacA as a Vaccine Antigen.

Authors:  Mati Moyat; Dominique Velin
Journal:  Toxins (Basel)       Date:  2016-06-08       Impact factor: 4.546

10.  Analysis of Helicobacter pylori Genotypes Amongst Jordanians' Dental Plaque Samples.

Authors:  Mohammad Abu-Lubad; Hamed Alzoubi; Dua'a Jarajreh; Alaa Al Sawalqa; Holger Bruggemann; Eman Albataineh; Amin Aqel; Munir Al-Zeer
Journal:  Gastroenterology Res       Date:  2018-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.